Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Cancer Screening Equipment Supplied In Europe
34 equipment items found
by:Oncgnostics GmbH based inJena, GERMANY
GynTect® enables the simple and reliable detection of methylated DNA regions in cervical scrapes. Methylation of GynTect® biomarkers occurs specifically in cervical cancer or its precursors, but not in samples from healthy women. Thus, GynTect® can help to clarify whether there is already a tissue alteration that needs to be ...
Manufactured by:Kaltek S.r.l. based inSaonara (PD), ITALY
Scrapers for cytological sampling. Medical devices used in gynecology to sample ectocervix and posterior fornix in cervical cancer screening procedures (PAP test.). ...
Manufactured by:Becton Dickinson and Company (BD) based inFranklin Lakes, NEW JERSEY (USA)
The BD SurePath™ liquid-based Pap test provides advantages over conventional Pap smears and other liquid-based cytology (LBC) tests, resulting in greater disease ...
by:Numares GROUP Corp based inRegensburg, GERMANY
Cancer is among the leading causes of death worldwide. Approximately 38 % of men and women will be diagnosed with cancer at some point during their lifetimes (based on 2013 – 2015 data1). Cancer can occur in any organ and in any cell type and the variability in clinical presentation makes early diagnosis difficult. Common cancers with established benefit of early diagnosis but for ...
by:Binx Health, Inc. based inCambridge, MASSACHUSETTS (USA)
Tests for HPV. Who is this for? Women over 30 should have an HPV screening once every 5 years if previous Pap tests for cervical cancer screening have been ...
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The detection of hemoglobin in stool can be used as a marker for gastrointestinal bleeding for colorectal cancer screening. Blood in the stool can come from tumors or polyps in the intestine, among other sources. If hemoglobin has been detected, a colonoscopy must be performed to determine whether the bleeding is actually from a tumor or a precancerous lesion. ...
Manufactured by:SurgiMab based inMontpellier, FRANCE
As opposed to an indiscriminate contrast agent, this ability to specifically highlight malignant tissue during a procedure opens up a broad market in both surgical tumor resection (FluorescenceGuided Surgery) and potentially also in cancer ...
Manufactured by:Newmars Technologies Ltd. based inBudapest, HUNGARY
Cervical Cancer is the 2nd most common cancer afflicting women worldwide [1]. In many countries, cervical cancer screening programs utilize a Pap test. If the Pap result is abnormal a visual examination called colposcopy, and in many instances one or more biopsies of the cervix is preformed to detect abnormal cervical tissue. ...
Manufactured by:BIOHIT Healthcare Ltd based inEllesmere Port, UNITED KINGDOM
The detection of haemoglobin in stool samples can be used as a marker of gastrointestinal bleeding as part of a colorectal cancer screening initiative. Hidden traces of blood in the stool can originate from tumours or polyps (lesions) in the lower gastrointestinal tract so when haemoglobin is detected in stool samples it is indicative of the presence of such ...
Manufactured by:Avant Medical B.V. based inGeffen, NETHERLANDS
ichroma II is an automatic or semiautomatic in-vitro diagnostic device that measures the concentration of analytes, contained in blood, urine, or other samples, in quantitative or semi-quantitative ways. Compared to the fi rstgeneration device, ichroma™, ichroma™ II has an improved user interface and display and an advanced optical system, which provide the user with disease test ...
Manufactured by:BioMaxima SA based inLublin, POLAND
BioMaxima was the first in Poland to start production of rapid diagnostic tests. The most popular and flagship product is the fecal occult blood test used for the diagnosis of colorectal cancer. We offer tests for infectious diseases, inflammatory and cancer markers and addictive drugs. Every year, based on the requirements of customers, we are expanding our offer with new diagnostic ...
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. ...
Manufactured by:Menssana Research Inc. based inEdgewater, NEW JERSEY (USA)
It takes 300 screening mammograms to discover one woman with breast cancer. A breath test might improve this very low yield. Researchers have known for many years that women with breast cancer have abnormal volatile organic compounds (VOCs) in their breath. Clinical studies at Menssana Research have shown that these breath VOCs can accurately ...
Manufactured by:Salofa Oy based inSalo, FINLAND
The FOB test (Faecal Occult Blood Test) is a rapid test of blood in the stool. The FOB test measures the condition of the gastrointestinal tract by detecting haemoglobin in the blood of a stool sample. The test is suitable for detecting intestinal bleeding and helps, for example, in diagnosing colorectal cancer. The test package includes a disposable test cartridge. ...
Manufactured by:Micrima Limited based inBristol, UNITED KINGDOM
Micrima are aiming to open up breast screening to all women. With breast cancer being the most common cancer in women of all ages globally, we believe that all women should be able to have breast screening. The current option for screening is mammography, which has limitations in women with dense breasts. ...
Manufactured by:Epigenomics AG based inBerlin, GERMANY
Colorectal cancer is curable in about 90% of cases if detected early. Nevertheless, this disease is one of the most frequent causes of cancer-related deaths in the industrialized world. Regular screening can prevent colorectal cancer. Epi proColon® offers a convenient way of detecting colorectal cancer: in ...
Manufactured by:2A Pharma ApS based inAalborg Øst, DENMARK
2A Pharma’s AAVLP-HER2/Neu peptide vaccine candidate has in laboratory tests been shown to induce antibodies specific to human HER2. In mouse models, regression of breast cancer tumors was observed after vaccination. In a proof-of-principle study carried out at the Medical University of Vienna, Austria, supported by Medigene AG, it was concluded that this vaccine strategy could help to ...
Manufactured by:Exscientia based inOxford, UNITED KINGDOM
In the landmark study, it was demonstrated for the first time that our functional precision-oncology platform can improve patient outcome in a prospective interventional ...
Manufactured by:Lobeck Medical AG based inFrick / Schweiz, SWITZERLAND
This testkit helps to save lives all over the world! The MediSmart colorectal occult blood test is an immunochemical test which also makes it possible for users to test for FOB (Fecal Occult Blood) in the comfort of their own home. The test is extremely accurate (more than 99,5%) and has been designed to detect extremely low levels of human fecal occult ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
The product has been evaluated in pre-clinical studies and a peer-reviewed article in the journal Scientific Reports, from Nature, was published which examined the effect of the cells in over 50 lines of human cancerous cells. The results showed that PLX-Immune cells exhibited an anti-proliferative effect on 45 percent of the tested cancer cell lines, with a ...